Fig. 4From: Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitorsThe selected pharmacophore model (Ph4-4) (distances in Å)Back to article page